Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
A Vijenthira, I Gong, SD Betschel, M Cheung… - Blood …, 2021 - ashpublications.org
The objective of this study was to perform a systematic review of the literature on vaccine
responsiveness in patients who have received anti-CD20 therapy. PubMed and EMBASE …
responsiveness in patients who have received anti-CD20 therapy. PubMed and EMBASE …
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in …
M Mikulska, S Cesaro, H de Lavallade… - The Lancet Infectious …, 2019 - thelancet.com
Patients with haematological malignancies are at high risk of infection because of various
mechanisms of humoral and cell-mediated immune deficiencies, which mainly depend on …
mechanisms of humoral and cell-mediated immune deficiencies, which mainly depend on …
[HTML][HTML] Influenza and pneumococcal vaccination in hematological malignancies: a systematic review of efficacy, effectiveness, and safety
G La Torre, A Mannocci, V Colamesta… - … of Hematology and …, 2016 - ncbi.nlm.nih.gov
Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic
Review of Efficacy, Effectiveness, and Safety - PMC Back to Top Skip to main content NIH …
Review of Efficacy, Effectiveness, and Safety - PMC Back to Top Skip to main content NIH …
Influenza vaccination rates among patients with a history of cancer: analysis of the National health interview survey
A Chang, MK Ellingson, CR Flowers… - Open Forum …, 2021 - academic.oup.com
Background Annual influenza vaccination is recommended for all patients with cancer, but
vaccine uptake data by cancer type and time since diagnosis are limited. We sought to …
vaccine uptake data by cancer type and time since diagnosis are limited. We sought to …
A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort
LS Kersun, A Reilly, SE Coffin, J Boyer… - Influenza and other …, 2013 - Wiley Online Library
Please cite this paper as: Kersun et al.(2013) A prospective study of chemotherapy
immunologic effects and predictors of humoral influenza vaccine responses in a pediatric …
immunologic effects and predictors of humoral influenza vaccine responses in a pediatric …
Adjuvanted influenza a (H 1 N 1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy‐treated patients
Background Patients with hematological malignancies are more susceptible to viral
infections including influenza. In 2009, the W orld H ealth O rganization classified the novel …
infections including influenza. In 2009, the W orld H ealth O rganization classified the novel …
Immunogenicity of a monovalent influenza A (H1N1) pdm09 vaccine in patients with hematological malignancies
Y Ide, Y Imamura, S Ohfuji, W Fukushima… - Human Vaccines & …, 2014 - Taylor & Francis
Patients with hematological malignancies have high risk for morbidity and mortality from
influenza. This study was conducted to evaluate the immunogenicity and reactogenicity of …
influenza. This study was conducted to evaluate the immunogenicity and reactogenicity of …
Influenza vaccination documentation rates during the first year after diagnosis of diffuse large B cell lymphoma
Introduction Influenza infection causes significant morbidity and mortality in patients with
cancer, and annual influenza vaccination for individuals with cancer is recommended. We …
cancer, and annual influenza vaccination for individuals with cancer is recommended. We …
Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy
RE Strowd, G Russell, FC Hsu, AF Carter… - Neuro-Oncology …, 2018 - academic.oup.com
Background For cancer patients, rates of influenza-associated hospitalization and death are
4 times greater than that of the general population. Previously, we reported reduced …
4 times greater than that of the general population. Previously, we reported reduced …
Influenza vaccine immunogenicity in patients with primary central nervous system malignancy
RE Strowd, K Swett, M Harmon, AF Carter… - Neuro …, 2014 - academic.oup.com
Background Patients with central nervous system (CNS) malignancies represent an “at-risk”
population for contracting influenza, particularly if they are receiving ongoing chemotherapy …
population for contracting influenza, particularly if they are receiving ongoing chemotherapy …